Engineering dendritic cell vaccines to improve cancer immunotherapy

被引：0
|
作者：
Caleb R. Perez
Michele De Palma
机构：
[1] École Polytechnique Fédérale de Lausanne (EPFL),Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences
来源：
Nature Communications | / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
At the interface between the innate and adaptive immune system, dendritic cells (DCs) play key roles in tumour immunity and hold a hitherto unrealized potential for cancer immunotherapy. Here we review the role of distinct DC subsets in the tumour microenvironment, with special emphasis on conventional type 1 DCs. Integrating new knowledge of DC biology and advancements in cell engineering, we provide a blueprint for the rational design of optimized DC vaccines for personalized cancer medicine.
引用
收藏
相关论文
共 50 条
  • [31] DNA vaccines targeting dendritic cells for the immunotherapy of cancer
    Tüting, T
    Wilson, CC
    Martin, DM
    Baar, J
    DeLeo, A
    Lotze, MT
    Storkus, WJ
    GENE THERAPY OF CANCER, 1998, 451 : 295 - 304
  • [32] Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies
    Kalinski, Pawel
    Muthuswamy, Ravikumar
    Urban, Julie
    EXPERT REVIEW OF VACCINES, 2013, 12 (03) : 285 - 295
  • [33] Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
    Pawel Kalinski
    Howard Edington
    Herbert J. Zeh
    Hideho Okada
    Lisa H. Butterfield
    John M. Kirkwood
    David L. Bartlett
    Immunologic Research, 2011, 50 : 235 - 247
  • [34] Third generation dendritic cell vaccines for tumor immunotherapy
    Frankenberger, Bernhard
    Schendel, Dolores J.
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2012, 91 (01) : 53 - 58
  • [35] Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
    Kalinski, Pawel
    Edington, Howard
    Zeh, Herbert J.
    Okada, Hideho
    Butterfield, Lisa H.
    Kirkwood, John M.
    Bartlett, David L.
    IMMUNOLOGIC RESEARCH, 2011, 50 (2-3) : 235 - 247
  • [36] DNA vaccines targeting dendritic cells for the immunotherapy of cancer
    Tuting, T
    Wilson, CC
    Martin, DI
    Baar, J
    DeLeo, A
    Storkus, WJ
    Lotze, MT
    CANCER GENE THERAPY, 1997, 4 (05) : 316 - 316
  • [37] Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
    Garg, Abhishek D.
    Coulie, Pierre G.
    Van den Eynde, Benoit J.
    Agostinis, Patrizia
    TRENDS IN IMMUNOLOGY, 2017, 38 (08) : 577 - 593
  • [38] Dendritic cell-based vaccines: From mouse models to clinical cancer immunotherapy
    Schreurs, FWJ
    Eggert, AAO
    Punt, CJA
    Figdor, CG
    Adema, GJ
    CRITICAL REVIEWS IN ONCOGENESIS, 2000, 11 (01): : 1 - 17
  • [39] Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results
    Lesterhuis, WJ
    de Vries, IJM
    Adema, GJ
    Punt, CJA
    ANNALS OF ONCOLOGY, 2004, 15 : 145 - 151
  • [40] Antibody engineering to improve cancer immunotherapy
    Peipp, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 118 - 118
12345